SCHEMBL9196201

SCHEMBL9196201

CC(=O)Nc1cc([N+](=O)[O-])c(F)cc1OCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
NPSR1 Q6W5P4 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 2/20 0.46
GALR2 O43603 1/20 0.46
MITF O75030 1/20 0.46
POLB P06746 1/20 0.46
HSP90AA1 P07900 1/20 0.46
XBP1 P17861 1/20 0.46
CCR6 P51684 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP19A1 P11511 1/20 0.45
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 2/20 0.40
PTPRB P23467 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PKM P14618 1/20 0.39
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10595113 0.90 ALDH1A1 (0.51) ALDH1A1MAPTNPSR1HPGDLMNA
SCHEMBL9199380 0.86 ALDH1A1 (0.54) ALDH1A1MAPTNPSR1HPGDLMNA
SCHEMBL18038909 0.83 ALDH1A1 (0.49) ALDH1A1MAPTNPSR1HPGDLMNA
SCHEMBL29537950 0.82 MEN1 (0.56) ALDH1A1MAPTKMT2AMEN1PKM
SCHEMBL9863292 0.82 MEN1 (0.56) ALDH1A1MAPTKMT2AMEN1PKM
SCHEMBL9199114 0.79 HPGD (0.43) ALDH1A1HPGDPOLBKMT2AMEN1
SCHEMBL7650190 0.79 CYP19A1 (0.67) MAPTCYP19A1KMT2AMEN1BRD4
SCHEMBL27238124 0.78 CYP19A1 (0.52) ALDH1A1MAPTHPGDSMN1; SMN2CYP19A1
SCHEMBL9846808 0.78 SMN1; SMN2 (0.48) ALDH1A1MAPTNPSR1HPGDLMNA
SCHEMBL30763475 0.78 SMN1; SMN2 (0.48) ALDH1A1MAPTNPSR1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0631579-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED D,L-2-(7-FLUORO-3,4-DIHYDRO-3-OXO-2H-1,4-BENZOXAZIN-6-YL)-PERHYDROIMIDAZO 1,5-A]PYRIDINE-1,3-DIONES SCHERING AKTIENGESELLSCHAFT (DE) 1995-01-04 EP claimed
WO-1993019065-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED D,L-2-(7-FLUORO-3,4-DIHYDRO-3-OXO-2H-1,4-BENZOXAZIN-6-YL)-PERHYDROIMIDAZO[1,5-A]PYRIDINE-1,3-DIONES SCHERING AKTIENGESELLSCHAFT (DE) 1993-09-30 WO claimed
EP-0517812-A4 ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT MERCK & CO INC (US) 1995-10-18 EP disclosed
EP-0631579-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED D,L-2-(7-FLUORO-3,4-DIHYDRO-3-OXO-2H-1,4-BENZOXAZIN-6-YL)-PERHYDROIMIDAZO 1,5-A]PYRIDINE-1,3-DIONES SCHERING AKTIENGESELLSCHAFT (DE) 1995-01-04 EP disclosed
EP-0596963-A1 PROCESS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF SUBSTITUTED 6-(3,5,6,7-TETRAHYDROPYRROLO 2,1-c] 1,2,4]THIADIAZOLE-3-YLIDENAMINO)-7-FLUORO-2H-1,4-BENZOXAZIN-3(4H)-ONES SCHERING AKTIENGESELLSCHAFT (DE) 1994-05-18 EP disclosed
WO-1993019065-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF SUBSTITUTED D,L-2-(7-FLUORO-3,4-DIHYDRO-3-OXO-2H-1,4-BENZOXAZIN-6-YL)-PERHYDROIMIDAZO[1,5-A]PYRIDINE-1,3-DIONES SCHERING AKTIENGESELLSCHAFT (DE) 1993-09-30 WO disclosed
WO-1993003043-A1 PROCESS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF SUBSTITUTED 6-(3,5,6,7-TETRAHYDROPYRROLO[2,1-c][1,2,4]THIADIAZOLE-3-YLIDENAMINO)-7-FLUORO-2H-1,4-BENZOXAZIN-3(4H)-ONES SCHERING AKTIENGESELLSCHAFT (DE) 1993-02-18 WO disclosed
EP-0517812-A1 ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT MERCK & CO. INC. (US) 1992-12-16 EP disclosed